research Induction of T Cell Exhaustion by JAK1/3 Inhibition in the Treatment of Alopecia Areata
Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.
Search
forProducts matching "areata alopecia"
Tracking 1 products like 217 Hair Tonic 15% (Oil Base) from by companies like ZeeMoreUncle. View product »
Sort by
Research
930-960 / 1000+ results
research Gut Microbiota in Alopecia Areata
Alopecia areata may be linked to imbalanced gut bacteria.
research Oral Tofacitinib for the Treatment of Alopecia Areata in Pediatric Patients
Tofacitinib taken by mouth helps treat hair loss in children.
research Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.
research Serum Level of Macrophage Migration Inhibitory Factor in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.
research Lack of Response to Laser Comb in Spontaneous and Graft-Induced Alopecia Areata in C3H/HeJ Mice
The laser comb did not improve hair regrowth in mice with alopecia areata.
research Alopecia Areata - Vitiligo Overlap Syndrome: An Emerging Clinical Variant
Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.
research Prognostic Factors That Affect the Response to Topical Treatment in Patchy Alopecia Areata
Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.
research Serum Holotranscobalamin, Vitamin B12, Folic Acid, and Homocysteine Levels in Alopecia Areata Patients
Alopecia areata is not linked to vitamin B12 deficiency.
research Comparison of Treatment with Clobetasol Propionate 0.05% and Topical Pimecrolimus 1% in Alopecia Areata
Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.
research Congenital Triangular Alopecia: A Close Mimicker of Alopecia Areata
CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.
research Effects of Diphencyprone on Expression of Bcl-2 Protein in Patients with Alopecia Areata
Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.
research Linear Lichen Planus Distributed in the Lines of Blaschko Developing During Intramuscular Triamcinolone Acetonide Therapy for Alopecia Areata Multiplex
Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.
research Two Cases of Alopecia Areata Responsive to Fexofenadine
Fexofenadine may help treat alopecia areata.
research Vitamin D Receptor Gene Polymorphisms Are Not Associated With Alopecia Areata
Vitamin D receptor gene variations are not linked to alopecia areata.
research Failure to Induce Alopecia Areata in C3H/HeJ Mice with Exogenous Interferon Gamma
Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.
research Alopecia Areata And Relapsing Polychondritis Or Mosaic Autoimmunity? The First Experience Of Co-Trimoxazole Treatment
Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.
research Clinical Presentations of Alopecia Areata
Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.
research Janus Kinase Inhibitors For Alopecia Areata
JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.
research Systematic Review of Newer Agents for the Management of Alopecia Areata in Adults: Janus Kinase Inhibitors, Biologics and Phosphodiesterase-4 Inhibitors
New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.
research Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.
research Trichoscopy as an Evaluation Method for Alopecia Areata Treatment: A Comparative Study
Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.
research Utility of Azathioprine, Methotrexate, and Cyclosporine as Steroid-Sparing Agents in Chronic Alopecia Areata: A Retrospective Study of Continuation Rates in 138 Patients
Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.
research Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis
Dupilumab for skin problems might reactivate hair loss in some patients.
research Genetic Analysis of Interleukin 18 Gene Polymorphisms in Alopecia Areata
Certain IL-18 gene variations may increase the risk of alopecia areata.
research An Overview of the Biology of Platelet-Rich Plasma and Microneedling as Potential Treatments for Alopecia Areata
Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.
research Higher Concentrations of Dithranol Appear to Induce Hair Growth Even in Severe Alopecia Areata
Higher concentrations of dithranol can help regrow hair in severe alopecia areata.
research Mechanisms of Tolerance and Potential Therapeutic Interventions in Alopecia Areata
Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.
research Intramuscular Triamcinolone Acetonide: An Undervalued Option for Refractory Alopecia Areata
Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.
research Childhood Epidermolysis Bullosa Acquisita During Squaric Acid Dibutyl Ester Immunotherapy for Alopecia Areata
A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.